RT Journal Article
SR Electronic
T1 The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.11.20172643
DO 10.1101/2020.08.11.20172643
A1 Yang Liu
A1 Christian Morgenstern
A1 James Kelly
A1 Rachel Lowe
A1 CMMID COVID-19 Working Group
A1 Mark Jit
YR 2020
UL http://medrxiv.org/content/early/2020/08/12/2020.08.11.20172643.abstract
AB Introduction Non-pharmaceutical interventions (NPIs) are used to reduce transmission of SARS coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19). However, empirical evidence of the effectiveness of specific NPIs has been inconsistent. We assessed the effectiveness of NPIs around internal containment and closure, international travel restrictions, economic measures, and health system actions on SARS-CoV-2 transmission in 130 countries and territories.Methods We used panel (longitudinal) regression to estimate the effectiveness of 13 categories of NPIs in reducing SARS-CoV-2 transmission with data from January - June 2020. First, we examined the temporal association between NPIs using hierarchical cluster analyses. We then regressed the time-varying reproduction number (Rt) of COVID-19 against different NPIs. We examined different model specifications to account for the temporal lag between NPIs and changes in Rt, levels of NPI intensity, time-varying changes in NPI effect and variable selection criteria. Results were interpreted taking into account both the range of model specifications and temporal clustering of NPIs.Results There was strong evidence for an association between two NPIs (school closure, internal movement restrictions) and reduced Rt. Another three NPIs (workplace closure, income support and debt/contract relief) had strong evidence of effectiveness when ignoring their level of intensity, while two NPIs (public events cancellation, restriction on gatherings) had strong evidence of their effectiveness only when evaluating their implementation at maximum capacity (e.g., restrictions on 1000+ people gathering were not effective, restrictions on <10 people gathering was). Evidence supporting the effectiveness of the remaining NPIs (stay-at-home requirements, public information campaigns, public transport closure, international travel controls, testing, contact tracing) was inconsistent and inconclusive. We found temporal clustering between many of the NPIs.Conclusion Understanding the impact that specific NPIs have had on SARS-CoV-2 transmission is complicated by temporal clustering, time-dependent variation in effects and differences in NPI intensity. However, the effectiveness of school closure and internal movement restrictions appears robust across different model specifications taking into account these effects, with some evidence that other NPIs may also be effective under particular conditions. This provides empirical evidence for the potential effectiveness of many although not all the actions policy-makers are taking to respond to the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYL and MJ are funded by the National Institute of Health Research (UK)(16/137/109), the Bill & Melinda Gates Foundation (INV-003174), and the European Commission (101003688). This research was partly funded by the National Institute for Health Research (NIHR) (16/137/109) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care. This research is partly funded by the Bill & Melinda Gates Foundation (INV-003174). The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Bill & Melinda Gates Foundation. YL is also supported by the UK Medical Research Council (MC_PC_19065). CM and JK are employed by IPM Informed Portfolio Management. IPM is appreciative of the contributions of its employees above and beyond the scope of their work, their dedication to the community and the world as a whole. The views expressed herein are made in a personal capacity and are not those necessarily made, sponsored, affiliated or endorsed by IPM. RL is a UK Royal Society Dorothy Hodgkin Fellow.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:London School of Hygiene and Tropical MedicineAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is availability through database described in this manuscript. Code used can be found here [https://github.com/yangclaraliu/COVID19_NPIs_vs_Rt]. https://github.com/yangclaraliu/COVID19_NPIs_vs_Rt